Position in QUCY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,280
New position
Shares Held
4,000
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 18 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $17,913,596 across 42 Diagnostics & Research names. QUCY ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
22,531 | $3,380,325 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
5,984 | $3,000,137 | |
| 3 | ILMN |
Illumina, Inc.
|
12,857 | $2,260,646 | |
| 4 | DHR |
Danaher Corp /De/
|
11,068 | $2,108,232 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
1,661 | $879,648 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
1,401 | $737,542 | |
| 7 | RVTY |
Revvity, Inc.
|
5,871 | $653,206 | |
| 8 | A |
Agilent Technologies, Inc.
|
4,814 | $639,443 |
All Filings in QUCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,280 | 4,000 | Shares | Other | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||